The Report “Global Cardiac Biomarkers Market 2014-2018” is now available at lifescienceindustryresearch.com. Contact sales@lifescienceindustryresearch.com Phone with “Global Cardiac Biomarkers Market 2014-2018″ in subject line and your contact details to purchase this report or get your questions answered. The collection of ‘Biotechnology’ market research reports has a new addition of “Global Cardiac Biomarkers Market 2014-2018” on Lifescienceindustryresearch.com. Analysts forecast the Global Cardiac Biomarkers market to grow at a CAGR of 12.75 percent over the period 2013-2018. A cardiac biomarker is defined as a measurable substance that is an indicator used in the diagnosis and risk stratification related to cardiovascular disease (CVDs) such as acute coronary syndrome (ACS), coronary syndromes, myocardial infarction (MI), and heart failure. Some of the cardiac biomarkers include creatine kinase (CK) MB, troponins (cTnI and cTnT), BNP, NTproBNP, GFAP, H-FABP, LDH isoenzymes, D-dimer, IMA, MPO, myoglobin, and sCD40L. Cardiac biomarker assays help medical professionals to understand and differentiate between myocardial infarction and angina, which assists in the diagnosis and treatment of CVDs. The abnormal concentration of these biomarkers will act as significant predictors of an adverse cardiovascular condition. Cardiac point of care (POC) testing offers reliable measurement of cardiac biomarkers and provides results within one hour of testing. In addition to saving time, some cardiac POC tests have been modified to improve the accuracy of the measurement of enzymes to reduce operational error.
Covered in this Report This report covers the present scenario and the growth prospects of the Global Cardiac Biomarkers market for the period 2014-2018. To calculate the market size, the report considers the revenue generated through the sales of devices and assays used for cardiac biomarkers to diagnose various cardiovascular diseases. Purchase a copy of this report @ http://www.lifescienceindustryresearch.com/purchase?rname=24988 .
The market is segmented based on the following type of assay: Troponin (cTnI and cTnT) BNP & NT-proBNP CK-MB Myogloblin